Cargando…

Analysis of CXCR5(+)Th17 cells in relation to disease activity and TNF inhibitor therapy in Rheumatoid Arthritis

Th17 and TfH cells are thought to promote tissue inflammation and autoantibody production, respectively, in autoimmune diseases including rheumatoid arthritis (RA). TfH cells that co-express Th17 markers (CXCR5(+)Th17) encompass both of these pathogenic functions, and are increased in some human aut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Deepika, Henkel, Matthew, Sendon, Bernadette, Feng, June, Fabio, Anthony, Metes, Diana, Moreland, Larry W., McGeachy, Mandy J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177940/ https://www.ncbi.nlm.nih.gov/pubmed/28004828 http://dx.doi.org/10.1038/srep39474

Ejemplares similares

Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses
por: Bishu, Shrinivas, et al.
Publicado: (2014)

CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis
por: Hernandez-Mir, Gerard, et al.
Publicado: (2017)

Matrix reboot: IL-17 signals CAFs to create a second tumor T cell checkpoint
por: McGeachy, Mandy J.
Publicado: (2022)

The metabolism-modulating activity of IL-17 signaling in health and disease
por: Bechara, Rami, et al.
Publicado: (2021)

Inflammatory Th17 Cells Express Integrin α(v)β(3) for Pathogenic Function
por: Du, Fang, et al.
Publicado: (2016)

The RNA-binding protein IMP2 drives a stromal-Th17 cell circuit in autoimmune neuroinflammation
por: Bechara, Rami, et al.
Publicado: (2022)

Unmet needs in rheumatoid arthritis
por: Moreland, Larry
Publicado: (2005)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker
por: Hwang, Yong Gil, et al.
Publicado: (2016)

Noncanonical STAT3 activity sustains pathogenic Th17 proliferation and cytokine response to antigen
por: Poholek, Catherine H., et al.
Publicado: (2020)

Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α–Dependent, IL-17–Independent Mechanism
por: Whibley, Natasha, et al.
Publicado: (2015)

Intermediate monocytes correlate with CXCR3(+) Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis
por: Drevinge, Christina, et al.
Publicado: (2021)

TH-17 cells in rheumatoid arthritis
por: Shahrara, Shiva, et al.
Publicado: (2008)

Th17 in Animal Models of Rheumatoid Arthritis
por: Hashimoto, Motomu
Publicado: (2017)

B cell targeted therapy: a new approach to the treatment of rheumatoid arthritis
por: Moreland, Larry
Publicado: (2005)

Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
por: Vitales-Noyola, Marlen, et al.
Publicado: (2022)

Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
por: Chen, Der-Yuan, et al.
Publicado: (2011)

The Plasticity of Th17 Cells in the Pathogenesis of Rheumatoid Arthritis
por: Kotake, Shigeru, et al.
Publicado: (2017)

Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis
por: Hull, Dobrina N., et al.
Publicado: (2016)

Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis
por: Kugyelka, Reka, et al.
Publicado: (2016)

Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling
por: Boniface, Katia, et al.
Publicado: (2009)

Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
por: Patel, Aarat M, et al.
Publicado: (2010)

No effect of anti-TNF-α treatment on serum IL-17 in patients with rheumatoid arthritis
por: Sikorska, Dorota, et al.
Publicado: (2018)

ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
por: Kim, Hyun Jeong, et al.
Publicado: (2020)

TNFα Promotes Th17 Cell Differentiation through IL-6 and IL-1β Produced by Monocytes in Rheumatoid Arthritis
por: Zheng, Yingxia, et al.
Publicado: (2014)

Exogenous IL-2 Controls the Balance in Th1, Th17, and Treg Cell Distribution in Patients with Progressive Rheumatoid Arthritis Treated with TNF-Alpha Inhibitors
por: Kosmaczewska, Agata, et al.
Publicado: (2014)

Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling
por: Ghoreschi, Kamran, et al.
Publicado: (2010)

Rheumatoid arthritis bone marrow environment supports Th17 response
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2017)

Plasma interleukin-23 and circulating IL-17A(+)IFNγ(+) ex-Th17 cells predict opposing outcomes of anti-TNF therapy in rheumatoid arthritis
por: Millier, Melanie J., et al.
Publicado: (2022)

Temporary consumption of western diet trains the immune system to reduce future gut inflammation
por: Wu, Dongwen, et al.
Publicado: (2023)

T cell specific Cxcr5 deficiency prevents rheumatoid arthritis
por: Moschovakis, Georgios L., et al.
Publicado: (2017)

Bone and TNF in rheumatoid arthritis: clinical implications
por: Manara, Maria, et al.
Publicado: (2015)

Anti-TNF antibody therapy induces IL-17 suppressing regulatory T cells in patients with rheumatoid arthritis
por: McGovern, Jenny, et al.
Publicado: (2012)

Regulatory T cells enhance Th17 migration in psoriatic arthritis which is reversed by anti-TNF
por: Nguyen, Dao X., et al.
Publicado: (2021)

Intracellular expression of CXCR3 on rheumatoid arthritis synovial tissue cells
por: Krystufkova, O, et al.
Publicado: (2001)

Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections
por: Conti, Heather R., et al.
Publicado: (2014)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
por: Al-Rayes, Hannan, et al.
Publicado: (2011)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
por: Vial, Gaelle, et al.
Publicado: (2021)

T helper cells in synovial fluid of patients with rheumatoid arthritis primarily have a Th1 and a CXCR3(+)Th2 phenotype
por: Aldridge, Jonathan, et al.
Publicado: (2020)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
por: Said, Cynthia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f6dfnijti5jm6ulatafh3nlokg